Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010
- PMID: 25316828
- PMCID: PMC6546099
- DOI: 10.1093/infdis/jiu086
Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010
Abstract
Background: Poliovirus (PV) antibody seroprevalence studies assess population immunity, verify an immunization program's performance and vaccine efficacy, and guide polio eradication strategy. Namibia experienced a polio outbreak among adults in 2006, yet population seroimmunity was unknown.
Methods: We tested 2061 specimens from Namibian pregnant females aged 15-44 years for neutralizing antibody to PV types 1-3 (PV1-3); all females were sampled during the 2010 National HIV Sentinel Survey. We determined the proportion of females seropositive for PV antibody by 5-year age strata, and analyzed factors associated with seropositivity, including age, gravidity, human immunodeficiency virus (HIV) infection status, residence, and antiretroviral treatment, by log-binomial regression.
Results: The seroprevalence was 94.6% for PV1, 97.0% for PV2, and 85.1% for PV3. HIV-positive females had significantly lower seroprevalence than HIV-negative females for PV1 (91.8% vs 95.3%; P<.01) and PV3 (80.0% vs 86.1%; P<.01) but not for PV2 (96.4% vs 97.1%; P=.3). The prevalence ratio of seropositivity for HIV-positive females versus HIV-negative females was 0.95 (95% confidence interval [CI], .92-.98) for PV1, 0.99 (95% CI, .97-1.01) for PV2, and 0.92 (95% CI, .87-.96) for PV3.
Conclusions: Despite relatively high PV seroprevalence, Namibia might remain at risk for a PV outbreak, particularly in lower-seroprevalence populations, such as HIV-positive females. Namibia should continue to maintain high routine polio vaccination coverage.
Keywords: HIV; Namibia; OPV; adults; neutralizing antibody; polio; poliovirus; population immunity; pregnant women; seroprevalence.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Conflict of interest statement
All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Similar articles
-
Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.Vaccine. 2013 Oct 1;31(42):4911-6. doi: 10.1016/j.vaccine.2013.06.106. Epub 2013 Jul 24. Vaccine. 2013. PMID: 23891502 Free PMC article.
-
Seroprevalence of poliovirus antibodies in Nigeria: refining strategies to sustain the eradication effort.Pan Afr Med J. 2023 Jul 13;45(Suppl 2):2. doi: 10.11604/pamj.supp.2023.45.2.38098. eCollection 2023. Pan Afr Med J. 2023. PMID: 38370104 Free PMC article.
-
A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.Vaccine. 2013 Apr 8;31(15):1987-93. doi: 10.1016/j.vaccine.2013.02.003. Epub 2013 Feb 18. Vaccine. 2013. PMID: 23429005
-
Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis.Vaccine. 2023 Jun 19;41(27):4057-4063. doi: 10.1016/j.vaccine.2023.04.047. Epub 2023 Apr 29. Vaccine. 2023. PMID: 37121798
-
Vaccination against polio should not be stopped.Nat Rev Microbiol. 2007 Dec;5(12):952-8. doi: 10.1038/nrmicro1769. Nat Rev Microbiol. 2007. PMID: 17965726 Review.
Cited by
-
Combination of lymphocyte number and function in evaluating host immunity.Aging (Albany NY). 2019 Dec 20;11(24):12685-12707. doi: 10.18632/aging.102595. Epub 2019 Dec 20. Aging (Albany NY). 2019. PMID: 31857499 Free PMC article.
-
On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000-2023, Namibia.Vaccines (Basel). 2024 Aug 23;12(9):957. doi: 10.3390/vaccines12090957. Vaccines (Basel). 2024. PMID: 39339990 Free PMC article.
-
Monitoring Results in Routine Immunization: Development of Routine Immunization Dashboard in Selected African Countries in the Context of the Polio Eradication Endgame Strategic Plan.J Infect Dis. 2017 Jul 1;216(suppl_1):S226-S236. doi: 10.1093/infdis/jiw635. J Infect Dis. 2017. PMID: 28838180 Free PMC article.
-
Placental antibody transfer efficiency and maternal levels: specific for measles, coxsackievirus A16, enterovirus 71, poliomyelitis I-III and HIV-1 antibodies.Sci Rep. 2016 Dec 9;6:38874. doi: 10.1038/srep38874. Sci Rep. 2016. PMID: 27934956 Free PMC article.
-
Maternal immunisation to improve the health of HIV-exposed infants.Lancet Infect Dis. 2019 Apr;19(4):e120-e131. doi: 10.1016/S1473-3099(18)30545-0. Epub 2018 Dec 7. Lancet Infect Dis. 2019. PMID: 30529212 Free PMC article. Review.
References
-
- Global Polio Eradication Initiative. Data and monitoring: wild poliovirus cases. http://www.polioeradication.org/Dataandmonitoring/Poliothisweek.aspx. Accessed 20 December 2013.
-
- Centers for Disease Control and Prevention. Outbreaks following wild poliovirus importations-Europe, Africa, and Asia, January 2009– September 2010. Morb Mortal Wkly Rep 2010; 59:1393–9. - PubMed
-
- Centers for Disease Control and Prevention. Notes from the field: poliomyelitis outbreak-republic of the Congo, September 2010–February 2011. Morb Mortal Wkly Rep 2011; 60:312–3. - PubMed
-
- 2001 Namibia Housing and Population Census. http://www.paris21.org/sites/default/files/825.pdf. Accessed 20 December 2013.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical